KWMG LLC’s iShares Biotechnology ETF IBB Stock Holding History

KWMG LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-189	Closed	-$21K	–	259
2019 Q1	$21K	Hold	189	–	–	0.01%	221
2018 Q4	$18K	Hold	189	–	–	﹤0.01%	228
2018 Q3	$23K	Hold	189	–	–	0.01%	211
2018 Q2	$21K	Buy	+189	New	+$20.2K	0.01%	212

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KWMG LLC's IBB Position: Q2 2019 in Review

KWMG LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 189 shares — an estimated $21K sold.

KWMG LLC first reported a position in IBB in Q2 2018 and held it in 4 quarters. The position peaked at $23K in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

KWMG LLC reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
KWMG LLC sold 189 iShares Biotechnology ETF shares in Q2 2019, an estimated $21K.
KWMG LLC first reported a position in iShares Biotechnology ETF in Q2 2018 and held it in 4 quarters.
KWMG LLC's iShares Biotechnology ETF position peaked at $23K in Q3 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on KWMG LLC's 13F filing for Q2 2019, filed 10 Jul 2019.